Amedisys(AMED)
Search documents
Amedisys(AMED) - 2021 Q1 - Earnings Call Transcript
2021-05-02 13:24
Amedisys, Inc. (NASDAQ:AMED) Q1 2021 Earnings Conference Call April 29, 2021 11:00 AM ET Company Participants Nick Muscato - SVP, Finance Paul Kusserow - Chairman & CEO Christopher Gerard - President & COO Scott Ginn - EVP & CFO Sharon Brunecz - Chief HR Officer Conference Call Participants Brian Tanquilut - Jefferies Matthew Larew - William Blair & Company A.J. Rice - Crédit Suisse Joanna Gajuk - Bank of America Merrill Lynch John Ransom - Raymond James & Associates Frank Morgan - RBC Capital Markets Justi ...
Amedisys(AMED) - 2020 Q4 - Earnings Call Transcript
2021-02-26 05:24
Amedisys, Inc. (NASDAQ:AMED) Q4 2020 Earnings Conference Call February 25, 2021 11:00 AM ET Company Participants Nick Muscato - Investor Relations Paul Kusserow - Chairman and Chief Executive Officer Chris Gerard - President and Chief Operating Officer Scott Ginn - Executive Vice President and Chief Financial Officer Dave Kemmerly - Chief Legal and Government Affairs Officer Conference Call Participants Brian Tanquilut - Jefferies Justin Bowers - Deutsche Bank A.J. Rice - Credit Suisse Andrew Mok - Barclays ...
Amedisys(AMED) - 2020 Q3 - Earnings Call Transcript
2020-10-31 21:53
Amedisys, Inc. (NASDAQ:AMED) Q3 2020 Results Conference Call October 29, 2020 11:00 AM ET Company Participants Nick Muscato - Senior Vice President of Finance Paul Kusserow - Chairman, CEO and President Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Dave Kemmerly - Chief Legal and Government Affairs Officer Conference Call Participants Brian Tanquilut - Jefferies Matt Larew - William Blair A.J. Rice - Credit Suisse Joanna Gajuk - Bank of America Matthew Gillmor - Baird Andrew M ...
Amedisys(AMED) - 2020 Q3 - Quarterly Report
2020-10-29 12:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-24260 AMEDISYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 11-3131700 (State or other jurisdiction o ...
Amedisys(AMED) - 2020 Q2 - Earnings Call Transcript
2020-07-30 00:07
Amedisys, Inc. (NASDAQ:AMED) Q2 2020 Earnings Conference Call July 29, 2020 11:00 AM ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - President & Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Conference Call Participants Brian Tanquilut - Jefferies Matt Larew - William Blair A.J. Rice - Credit Suisse Justin Bowers - Deutsche Bank Kevin Fischbeck - Bank of America John Ransom - Raymond James Operator Greetings, an ...